Helius Medical Technologies (NASDAQ:HSDT) Issues Quarterly Earnings Results

Helius Medical Technologies (NASDAQ:HSDT) posted its quarterly earnings results on Monday. The company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.50) by ($0.14), Zacks reports. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative return on equity of 297.49%. The company had revenue of $0.18 million for the quarter. During the same quarter in the prior year, the company posted ($3.00) EPS.

Helius Medical Technologies Stock Down 2.8 %

Shares of Helius Medical Technologies stock traded down $0.02 on Wednesday, hitting $0.73. 24,451 shares of the company traded hands, compared to its average volume of 326,727. The company has a 50-day moving average price of $0.91 and a 200 day moving average price of $3.33. Helius Medical Technologies has a 12-month low of $0.65 and a 12-month high of $13.43. The company has a market cap of $2.18 million, a PE ratio of -0.05 and a beta of 1.60.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.